226 Studies Now Enrolling
Menu
Search
Status
Medical Condition
- Show all (107)
- Autoimmune Disorders (6)
- Blood Disorders (33)
- Cancer (1)
- Endocrine & Metabolic Disease (1)
- Hair and Skin Disorders (2)
- Healthy Volunteers (5)
- Heart Disease (1)
- Kidney Disease (1)
- Lung Disease (2)
- Neurological Disorders (46)
- Obstetrics & Gynecology (1)
- Pediatrics (2)
- Psychiatric Disorders (6)
Displaying 1 - 2 of 2
Condition: Psychiatric Disorders / Bipolar Disorder
Investigator: Joshua Kantrowitz, Md
Status: Closed
We will evaluate the D-cycloserine (DCS) and lurasidone with MRI measurement of brain responses to DCS. DCS is a drug that works on the same brain receptor as ketamine. DCS is not approved by the FDA for bipolar depression. Study participants will receive a dose of lurasidone or placebo in one MRI and a dose of DCS in another, followed by an optional follow…
Condition: Blood Disorders / Anemia
Investigator: Katherine Ender, MD
Status: Closed
The main purpose of the study is to find out whether Triferic, when taken by mouth (orally) with Shohls solution, is safe and effective for the treatment of Iron Refractory Iron-Deficiency Anemia (IRIDA). The study drug, ferric pyrophosphate citrate (FPC), is also called Triferic. It is an iron salt that has been approved by the Food and Drug Administration…